pindolol has been researched along with Refractory Depression in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Zhou, X | 1 |
| Zhu, D | 1 |
| Chen, J | 1 |
| Qin, B | 1 |
| Zhang, Y | 1 |
| Wang, X | 1 |
| Yang, D | 1 |
| Meng, H | 1 |
| Luo, Q | 1 |
| Xie, P | 1 |
1 review available for pindolol and Refractory Depression
| Article | Year |
|---|---|
Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
Topics: Adult; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Pindolol; Psychi | 2015 |